Total Payments
$510,667
2024 Payments
$12,667
Companies
28
Transactions
568
Medicare Patients
1,509
Medicare Billing
$268,626
Payment Breakdown by Category
Other$239,417 (46.9%)
Consulting$203,759 (39.9%)
Travel$55,890 (10.9%)
Food & Beverage$11,369 (2.2%)
Education$232.44 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $230,167 | 106 | 45.1% |
| Consulting Fee | $203,759 | 70 | 39.9% |
| Travel and Lodging | $55,890 | 142 | 10.9% |
| Food and Beverage | $11,369 | 236 | 2.2% |
| Honoraria | $9,250 | 6 | 1.8% |
| Education | $232.44 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $351,359 | 336 | $0 (2024) |
| GlaxoSmithKline, LLC. | $45,480 | 21 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $37,667 | 58 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $17,614 | 20 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $16,334 | 7 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $11,046 | 5 | $0 (2021) |
| Otsuka Pharmaceutical Co., Ltd. | $7,758 | 13 | $0 (2018) |
| AstraZeneca UK Limited | $6,250 | 2 | $0 (2020) |
| Travere Therapeutics, Inc. | $5,505 | 9 | $0 (2023) |
| PFIZER INC. | $4,568 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,667 | 16 | AstraZeneca Pharmaceuticals LP ($8,708) |
| 2023 | $39,697 | 42 | GlaxoSmithKline, LLC. ($26,630) |
| 2022 | $90,000 | 88 | AstraZeneca Pharmaceuticals LP ($44,736) |
| 2021 | $67,511 | 76 | AstraZeneca Pharmaceuticals LP ($51,712) |
| 2020 | $102,367 | 89 | AstraZeneca Pharmaceuticals LP ($85,456) |
| 2019 | $152,881 | 156 | AstraZeneca Pharmaceuticals LP ($141,994) |
| 2018 | $25,589 | 59 | Fresenius USA Marketing, Inc. ($10,124) |
| 2017 | $19,955 | 42 | Fresenius USA Marketing, Inc. ($14,986) |
All Payment Transactions
568 individual payment records from CMS Open Payments — Page 3 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: Cardio-renal | ||||||
| 01/26/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/24/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $47.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $42.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/13/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Hyperkalemia | ||||||
| 01/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), LOKELMA | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 12/12/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/06/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.22 | General |
| 11/29/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $7,800.00 | General |
| 11/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/15/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $1,294.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $103.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,805.00 | General |
| Category: Cardio-renal | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $835.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Rare Disease | ||||||
| 10/28/2022 | Amgen Inc. | Aranesp (Biological), Parsabiv | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Nephrology | ||||||
| 10/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 516 | 1,434 | $278,020 | $105,126 |
| 2022 | 6 | 312 | 772 | $124,428 | $48,930 |
| 2021 | 8 | 393 | 895 | $195,783 | $73,675 |
| 2020 | 9 | 288 | 488 | $123,227 | $40,895 |
Total Patients
1,509
Total Services
3,589
Medicare Billing
$268,626
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 48 | 51 | $26,775 | $9,748 | 36.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 68 | $11,900 | $6,536 | 54.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 16 | 46 | $15,525 | $3,173 | 20.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 16 | 16 | $6,400 | $3,035 | 47.4% |
| 90937 | Hemodialysis procedure with repeated evaluations | Facility | 2020 | 11 | 15 | $11,228 | $1,461 | 13.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 13 | $13,000 | $536.14 | 4.1% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 46 | 56 | $840.00 | $223.60 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 46 | 58 | $435.00 | $172.86 | 39.7% |
About Dr. Bruce Spinowitz, M.D
Dr. Bruce Spinowitz, M.D is a Nephrology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467475962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Spinowitz, M.D has received a total of $510,667 in payments from pharmaceutical and medical device companies, with $12,667 received in 2024. These payments were reported across 568 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($230,167).
As a Medicare-enrolled provider, Spinowitz has provided services to 1,509 Medicare beneficiaries, totaling 3,589 services with total Medicare billing of $268,626. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Bronx, NY
- Active Since 07/25/2006
- Last Updated 05/14/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1467475962
Products in Payments
- LOKELMA (Drug) $247,366
- Velphoro (Drug) $37,575
- FARXIGA (Drug) $26,669
- JESDUVROQ (Drug) $24,657
- Kerendia (Drug) $13,876
- Non-Covered (Drug) $3,738
- Velophoro (Drug) $1,050
- RETACRIT (Biological) $700.00
- Veltassa (Drug) $345.16
- AURYXIA (Drug) $204.47
- JYNARQUE (Drug) $192.01
- Parsabiv (Biological) $149.65
- Vaprisol (Drug) $132.81
- Parsabiv (Drug) $112.95
- RAYALDEE (Drug) $109.10
- INJECTAFER (Drug) $98.37
- LUPKYNIS (Drug) $86.72
- ULTOMIRIS (Biological) $73.75
- SAMSCA (Drug) $70.14
- XARELTO (Drug) $68.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Bronx
Joel Neugarten, Md, MD
Nephrology — Payments: $384,806
Nephrology $384,806
Enver Akalin, M.d, M.D
Nephrology — Payments: $76,364
Nephrology $76,364
John He, Md, MD
Nephrology — Payments: $24,885
Nephrology $24,885
Abdurhman Ahmed, M.d, M.D
Nephrology — Payments: $12,466
Nephrology $12,466
Dr. Suman Reddy, Md, MD
Nephrology — Payments: $7,783
Nephrology $7,783
Mr. Joseph Bonanno, D.o, D.O
Nephrology — Payments: $7,333
Nephrology $7,333